Show news: from last 30 days (default), 60 days, 90 days, last visit or all

Valproate further prescribing resources

30th April 2019

The following resources are available to support the prescribing of valproate in females of child-bearing potential. For more information on the risks of valproate in pregnancy, see our previous news item in April 2018.

Pan college guidance

This has been produced by experts from 13 national healthcare bodies, including Royal Colleges and the Royal Pharmaceutical Society for use in the authorised indications of epilepsy and bipolar disorders. It advises on the more challenging issues that health professionals in primary and specialist care might encounter in daily practice, e.g. transition from paediatric to adult services, competence to consent to treatment, and confidentiality.

Click here to view


NICE has produced a summary of their guidance and safety advice for valproate, including for off-label indications.

Click here to view

Paediatric guidance

The British Paediatric Neurology Association (BPNA) and the Royal College of Paediatrics and Child Health (RCPCH) have developed joint guidance about the use of valproate in female patients <18 years.

Click here to view